药品名称 | MINOCIN | 申请号 | 050444 | 产品号 | 001 | 活性成分 | MINOCYCLINE HYDROCHLORIDE | 市场状态 | 处方药 | 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | EQ 100MG BASE/VIAL | 治疗等效代码 | | 参比药物 | 是 | 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | REMPEX PHARMACEUTICALS INC
| 化学类型 | | 审评分类 | | 罕用药/孤儿药 | 是 | | |
|
|
|
与本品相关的市场独占权保护信息 | 独占权代码 | 失效日期 | 无 | 历史市场独占权保护信息 | 无 |
|
与药品注册相关的信息 | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | 050444 | 049 | AP | Label | 2015/04/22 | 下载 | 050444 | 048 | AP | Letter | 2014/10/27 | 下载 | 050444 | 048 | AP | Label | 2014/11/18 | 下载 | 050444 | 047 | AP | Letter | 2010/09/17 | 下载 | 050444 | 047 | AP | Label | 2010/09/20 | 下载 | 050444 | 045 | AP | Label | 2007/01/18 | 下载 | 050444 | 045 | AP | Letter | 2007/01/18 | 下载 | 050444 | 044 | AP | Label | 2005/09/30 | 下载 | 050444 | 044 | AP | Letter | 2005/10/20 | 下载 | 050444 | 043 | AP | Letter | 2004/06/01 | 下载 | 050444 | 042 | AP | Letter | 2004/06/01 | 下载 | 050444 | 038 | AP | Letter | 2005/02/17 | 下载 | 050444 | 036 | AP | Review | 2004/06/29 | 下载 | 050444 | 036 | AP | Letter | 2002/05/31 | 下载 | 050444 | 034 | AP | Letter | 2002/01/30 | 下载 | 050444 | 033 | AP | Letter | 2002/01/30 | 下载 | 050444 | 029 | AP | Letter | 2002/01/30 | 下载 |
|
药品注册审批历史信息 | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | 050444 | 049 | AP | 2015/04/17 | Manufacturing Change or Addition | 050444 | 048 | AP | 2014/10/23 | Labeling Revision | 050444 | 047 | AP | 2010/09/14 | Labeling Revision | 050444 | 045 | AP | 2007/01/16 | Labeling Revision | 050444 | 044 | AP | 2005/09/28 | Labeling Revision | 050444 | 043 | AP | 2004/05/27 | Labeling Revision | 050444 | 042 | AP | 2004/05/27 | Labeling Revision | 050444 | 038 | AP | 2005/02/17 | Labeling Revision | 050444 | 037 | AP | 2001/06/21 | Manufacturing Change or Addition | 050444 | 036 | AP | 2002/05/31 | Labeling Revision | 050444 | 035 | AP | 1997/07/29 | Control Supplement | 050444 | 034 | AP | 2002/01/30 | Labeling Revision | 050444 | 033 | AP | 2002/01/30 | Labeling Revision | 050444 | 031 | AP | 1996/03/29 | Labeling Revision | 050444 | 030 | AP | 1996/03/04 | Control Supplement | 050444 | 029 | AP | 2002/01/30 | Labeling Revision | 050444 | 028 | AP | 1978/06/27 | Control Supplement | 050444 | 027 | AP | 1978/04/12 | Labeling Revision | 050444 | 025 | AP | 1978/07/12 | Control Supplement | 050444 | 024 | AP | 1978/06/08 | Control Supplement | 050444 | 022 | AP | 1977/01/14 | Control Supplement | 050444 | 021 | AP | 1976/08/11 | Manufacturing Change or Addition | 050444 | 020 | AP | 1976/06/25 | Control Supplement | 050444 | 018 | AP | 1975/12/24 | Control Supplement | 050444 | 017 | AP | 1975/05/12 | Formulation Revision | 050444 | 016 | AP | 1975/03/21 | New Dosage Regimen | 050444 | 014 | AP | 1974/11/04 | Labeling Revision | 050444 | 013 | AP | 1973/10/04 | Labeling Revision | 050444 | 012 | AP | 1973/08/31 | Formulation Revision | 050444 | 011 | AP | 1973/06/28 | Control Supplement | 050444 | 010 | AP | 1973/02/08 | Formulation Revision | 050444 | 009 | AP | 1992/05/12 | Labeling Revision | 050444 | 008 | AP | 1991/08/28 | Labeling Revision | 050444 | 006 | AP | 1988/11/07 | Control Supplement | 050444 | 004 | AP | 1987/10/06 | Labeling Revision | 050444 | 002 | AP | 1986/01/10 | Labeling Revision | 050444 | 001 | AP | 1984/07/25 | Control Supplement | 050444 | 000 | AP | 1972/10/26 | Approval |
|